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Abstract 
Multiple pterygium syndrome (MPS) disorders are a phenotypically and genetically 
heterogeneous conditions characterised by multiple joint contractures (arthrogryposis), 
pterygia (joint webbing) and other developmental defects. MPS is most frequently inherited 
in an autosomal recessive fashion but X-linked and autosomal dominant forms also occur. 
Advances in genomic technologies have identified many genetic causes of MPS-related 
disorders and genetic diagnosis requires large targeted next generation sequencing gene 
panels or genome-wide sequencing approaches. Using the Illumina TruSightOne clinical 
exome assay we identified a recurrent heterozygous missense substitution in TPM2 (encoding 
beta tropomyosin) in three unrelated individuals. This was confirmed to have arisen as a de 
novo event in the two patients with parental samples. TPM2 mutations have previously been 
described in association with a variety of dominantly inherited neuromuscular phenotypes 
including nemaline myopathy, congenital fibre-type disproportion, distal arthrogryposis and 
trismus pseudocamptodactyly, and in a patient with autosomal recessive Escobar syndrome 
and a nemaline myopathy. The three cases reported here had overlapping but variable 
features. Our findings expand the range of TMP2-related phenotypes and indicate that de 
novo TMP2 mutations should be considered in isolated cases of MPS-related conditions.  
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Multiple pterygium syndrome (MPS) disorders are phenotypically and genetically 
heterogeneous. MPS is subdivided into Escobar variant MPS (EVMPS) and a prenatally 
lethal form (LMPS). Both are characterised by multiples joint contractures (arthrogryposis), 
pterygia or webbing across the joints, fetal akinesia and congenital abnormalities. Pterygia 
occur with immobility and are believed to result from early fetal oedema or subcutaneous 
fluid in the joint region
1
 due to impaired connection between the venous and lymphatic 
systems.
2
 Pterygia may become apparent with time, suggesting progression in the formation 
of the pterygia can occur.
3,4
 LMPS and EVMPS have phenotypic overlap with fetal akinesia 
deformation sequence and other arthrogrypotic conditions respectively. MPS are most 
commonly autosomal recessively inherited although autosomal dominant and X-linked 
recessive families have been described.
5–9
 MPS results from fetal akinesia and biallelic 
pathogenic mutations in the embryonal gamma subunit of the acetylcholine receptor gene 
(CHRNG) are a major cause of both LMPS and EVMPS.
10,11
  Biallelic mutations in other 
fetal acetylcholine receptor function genes (CHRNA1, CHRND, RAPSN, DOK7 and MUSK) 
can also result in MPS.
12–17
 Other neuromuscular genes such as SMA, GLE1 in the anterior 
horn cell of the central nervous system
18,19
 and muscle such as ryanodine receptor-1, nebulin, 
actin, skeletal muscle alpha
20–23
 have been identified in patients with MPS. Genetic 
heterogeneity makes molecular diagnosis challenging nevertheless it is important as there 
may be health implications for the patient, and to provide accurate recurrence risk 
information and options such as prenatal and pre-implantation genetic diagnosis for families. 
We utilized an exome sequencing approach to identify a recurrent monoallelic pathogenic 
TPM2 variant in three unrelated children with an MPS spectrum disorder.  
  
Materials and Methods 
Patients with features of EVMPS were recruited to the study. All families gave informed 
consent. Clinical information was obtained from clinical questionnaires, medical records and 
clinical review. CHRNG was analysed and whole-exome sequencing (WES) undertaken in 
the  CHRNG negative probands and segregation studies performed as described in Appendix 
S1, Supporting Information. The study was approved by the South Birmingham Research 





Cases 1, 2 and 3 had arthrogryposis predominantly affecting distal joints, congenital 
anomalies and facial features reminiscent of EVMPS (see Figures 1a-1c). Cases 2 and 3 also 
had neck pterygia. All three individuals had short stature and coeliac disease was identified in 
case 1 and isolated growth hormone deficiency in case 2. Clinical features of cases 1-3 and 
published cases with a sequence change affecting the amino acid at position 133 are 






An identical heterozygous missense substitution in exon 4 of TPM2, c.397C>T 
(p.Arg133Trp), was detected in all three patients. Parental samples were available for cases 2 
and 3 and none of the parents carried the variant. The variant was not present in the Gnomad 
database (accessed 27/2/19) and was classified as pathogenic by ACMG criteria (using 
criteria PS2, PS4, PM2, PP5). 
 
Discussion  
Tropomyosins are a family of tissue specific protein isoforms.  Tropomyosin 2 (TPM2) 
encoding beta tropomyosin is mainly expressed in slow muscle fibres and to a lesser extent in 
fast muscle and heart muscle fibres.
24
 It is an important component of the skeletal muscle 
machinery and is intimately involved with other components such as actin and troponin in 
calcium regulated muscle contraction.
25
  
Mutations in TPM2 have been associated with a variety of phenotypes including nemaline 
myopathy, congenital fibre-type disproportion, cap myopathy, distal arthrogryposis and 
trismus pseudocamptodactly.
24,26–30
 The c.397C>T(p.Arg133Trp) variant predicted to be 
possibly damaging or damaging by PolyPhen-2 and FATHMM respectively was described in 
an adult mother and daughter with distal arthrogryposis type 2B and muscle weakness and in 
a patient with congenital fibre-type disproportion and progressive weakness.
30,31
 A further 
patient with a different missense substitution c.398G>C (pArg133Pro) affecting the same 




TPM2 loss of function mutations result in decreased calcium sensitivity and congenital 
muscle weakness whereas gain of function mutations cause a higher calcium sensitivity, 
hypercontractile state and arthrogryposis.
25
 Distal arthrogryposis with the p.R133W gain of 
function mutation would fit with a hypercontractile state secondary to an heightened 
sensitivity to calcium however this has not been demonstrated and instead there may be a 
reduction of myosin head molecules in the strong actin-binding state and altered myosin–
actin cross bridge kinetics resulting in muscle weakness without muscle wasting.
30,32
 Beta 
tropomyosin is the main isoform expressed in-utero in skeletal muscle.
33
 As arthrogryposis 
arises from fetal akinesia, the altered muscle contraction forces and decreased fetal 
movement provide a mechanism for congenital joint contractures. 
In the three cases harbouring the p.R133W mutation in our series, the joint contractures were 
also most marked distally and mild trismus was present in two of our three patients. Our 
patients had striking facial features and neck webbing reminiscent of Escobar variant MPS 
(EVMPS) and congenital anomalies . Neither patient described by Marttila et al
30
 was 
reported to have an EVMPS phenotype. This may have been because of a predominantly 
neuromuscular phenotype or because the pattern of features was not present or sufficiently 
distinctive. Interestingly, the adult mother and daughter reported by Tajsharghi et al
31
 
presented with distal arthrogryposis and other features including hearing impairment, short 
stature, a scoliosis, proximal joint contractures, a high-arched palate, micrognathia and a 
short neck, in the EVMPS spectrum. There is a single report of EVMPS and a nemaline 
myopathy with complete absence of the skeletal muscle isoform due to a homozygous null 
mutation in TPM2.
34
 Patient 1 was diagnosed with coeliac disease and patient 2 had isolated 
growth hormone deficiency. These may be coincidental findings however is possible that 
these complications are under-recognised in EVMPS as small stature may be considered part 
of the condition.  Importantly, the arthrogryposis in patients 1 and 2 improved with 
physiotherapy however improving joint contractures in patients with the p.R133W mutation 
has previously been noted.
31
 
The detection of identical TPM2 mutations in patients with distal arthrogryposis and those 
with additional features more characteristic of EVMPS suggest the phenotype is modified by 
other genetic and environmental factors. Furthermore, the coexistence of arthrogryposis and 
weakness suggests differential tissue specific factors. A possible explanation may be the 
extent to which other tropomyosin isoforms form heterodimers with beta tropomyosin under 
certain circumstances, altering its physical properties and affecting its role in muscle 
contraction. Further study of TPM2 mutations and variable phenotypes may identify of other 
important genetic modifiers and environmental factors and targets for future treatments. 
De novo TPM2 mutations are likely to be under-recognised as MPS may be presumed to 
result from biallelic recessively inherited mutations and testing for autosomal dominant 
causes may not be considered . This report adds to our knowledge of the genetic 
heterogeneity underlying the EVMPS and broadens the phenotypic variability associated with 
the R133W mutation. Importantly, as TPM2 is expressed in fetal and postnatal life, mutations 
may be associated with an evolving phenotype with improving joint contractures and possibly 
progressive weakness due to altered muscle kinetics over time. Therefore these individuals 
require follow up by a neuromuscular clinician as well as cardiorespiratory surveillance. 
Identification of an autosomal dominant TPM2 mutation will also inform the recurrence risk 
for the parents and the proband.   
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Fig.1a Case 1 age 6 years. Face i) periorbital fullness, broad nasal root and hypertelorism ii) 
bilateral finger contractures; age 10 years. Face iii) frontal view, iv) brachycephaly, low set 
posteriorly rotated ears and hearing aid v) mild trismus  
Fig. 1b Case 2 age 3 months. Face i) hypertelorism, short downslanting palpebral fissures, 
small mouth ii) brachycephaly, low set posteriorly rotated ears and short neck; age 5 years. 
Face iii) downslanting palebral fissures, small mouth and neck webbing  iv) flat facial profile 
and low set ears and arthogryposis of the v)lower limbs and vi) hands 
Fig 1c Case 3. i), Posterior view of low hairline, neck webbing and kyphoscoliosis, 
arthrogryposis ii) Lower limb athrogryposis and decreased muscle bulk iii) Feet with full 
heels and iv) Hand and finger contractures.  
Figure 2 Schematic of reported TPM2 mutations 
Table 1 Clinical features with a sequence change affecting the amino acid at position 133 












































































































Appendix S1, Supporting Information 
Molecular methods  
DNA was collected from blood samples using a standard extraction methodology. Targeted 
resequencing was performed using Illumina TruSightTM Rapid Capture kit to cover coding 
sequences from 4813 clinically relevant genes from the TruSightOne panel. Using Nextera 
library preparation technology, genomic DNA was fragmented and tagged prior to multiplex 
pre-enrichment sample pooling, an average 400bp fragment library size was achieved and a 
final pooled library concentration of 8-12Pm was assembled. For the assessment of the 
genomic library quality, 2100 Bioanalyzer tools (Agilent Technology) were used. Sequencing 
was performed on NGS Illumina’s HiSeq2500 analyser employing a pair-end 150-cycle 
sequencing run. Bioinformatics analysis and annotation of rare genetic variants was 
undertaken. Any variant reported >2% heterozygote frequency in 1,000 genomes project and 
variant exome server data (www.1000genomes.org/ and http://evs.gs.washington.edu/EVS/ 
respectively) was removed. Sequence data was inspected in a total of 86 candidate genes of 
potential relevance to MPS-related phenotypes. Variants identified as candidate pathogenic 
variants were confirmed by Sanger sequencing in the proband sample and segregation was 
checked in DNA from other available family members. PCR products were sequenced in 
forward and reverse orientations using a standard sequencing method (BigDye® Terminator 
v3.1 Cycle Sequencing Kit, Applied Biosystems®). 
 
Clinical details 
Case 1  
This female patient was the second child of unrelated white parents. From 34 weeks of 
pregnancy there was poor growth and reduced fetal movements. She was born at 41 weeks of 
pregnancy, birth weight 2.944 kg (13 percentile), length 43 cm (< 0.4 percentile) and head 
circumference 33.5 cm (25 percentile). Poor feeding and almost 10% weight loss of after 
birth weight required admission. Multiple joint contractures were present with ulna deviation 
and mild restriction of wrist movement, flexion contractures of fingers 2-5 and paucity of 
palmar creases. She had Bilateral congenital talipes equinovarus with full heels, full knee 
flexion but lacked 30 degrees of extension in her lower limbs. Her muscle bulk appeared 
normal with normal power in both quadriceps. Facially she had brachycephaly, periorbital 
fullness, a slightly broad nasal root and a smooth philtrum. She had a small mouth with 
slightly reduced mouth opening. She had a low posterior hairline. She required removal of a 
left brachial cyst remnant and grommets (see Figure 1). 
On review at aged 10 years her weight was 23.2 kg (2 percentile), her height was 129 cm (9 
percentile) and her head circumference was 50.8 cm (0.4 - 2 percentile). Fixed flexion 
contracture of her right 3rd finger proximal interphalangeal joint, her speech was slightly 
indistinct and nasal, and she had bone anchored hearing aids for bilateral conductive 
asymmetric hearing loss. Educational classroom support was in place in school because of 
difficulty retaining information. She was diagnosed with coeliac disease and commenced on a 
gluten free diet Prior CHRNG analysis was normal. 
 
 
Case 2  
The male proband is the second child of unrelated white parents. Antenatally there was 
polyhydramnios, decreased fetal movements, a right sided pleural effusion, bilateral talipes 
equinovarus and clenched hands. He was born by Caesarean section at 37 weeks, birth weight 
3.34 kg (32 percentile) and head circumference 36 cm (83 percentile). Nasogastric tube feeds 
were required for the first 4 weeks of life. On examination he had brachycephaly and 
dysmorphic features with mild hypertelorism and short downslanting palpebral fissures, a 
small mouth, a high palate, micrognathia, small low set posteriorly rotated ears, a short neck 
with mild neck webbing and widely spaced nipples (see Figure 2). Multiple joint contractures 
with ulna deviation, camptodactyly of fingers 2-5 and bilateral talipes equinovarus were 
present. There was good muscle bulk in the thighs but small calves. He had a small secundum 
atrial septal defect, a left inguinal herniaand bilateral undescended testicles.  
On review at the age 5 years his height and weight were around the 2 percentile and his head 
circumference was between the 2-9 percentiles. His diet was supplemented with high calorie 
milk and he a laxative for constipation. He had recurrent chest infections. Psychomotor 
development was delayed with walking achieved at 19 months however he could only 
manage short distances before tiring. He was toe walker with tightness of the ankles joints. 
He had mild fixed flexion deformities of elbows and knees and limited shoulder abduction on 
right. In the upper limbs windswept fingers with residual flexion contractures of fingers 2-5 
were present however there was good hand function. Speech improved with speech and 
language therapy and he was making progress with  classroom support at school. He wore 
glasses because of astigmatism and a right sided squint. 
By aged 9 years his height velocity had tailed off to 4 cm/year and investigations showed a 
delayed bone age, an IGF1 of 14nmol/l, at the lower end of normal and a suboptimal growth 
hormone peak of 3.9 mcg/L on an arginine stimulation test. Isolated growth hormone 
deficiency was confirmed on a glucagon stimulation test and growth hormone treatment 
commenced. On examination at 10 years of age his weight was 20.2 kg (< 0.4 percentile), 
height was123.4 cm (1 percentile) and head circumference was 51.4 cm (3 percentile. He had 
limited mouth opening and teeth erupting on the hard palate. There was chest wall asymmetry 
and a mild pectus excavatum., restriction of neck movement and the thoracic spine was 
slightly stiff. In the upper limb there was  asymmetry of the scapulae but no winging and a 
good range of shoulder movement. There were dimples and fixed flexion of both elbows with 
reduced pronation and supination and fixed flexion of the wrists. His fingers were flexed with 
pseudocamptodactyly and he had fixed flexion of the left index fingers with webbing across 
joint. In the lower limb his hips and knees were very mobile and he had a fixed hindfoot 
equinovarus bilaterally and a forefoot adductus. He walked on his tip toes with an equinus 
posture loading the lateral border of the feet and a midfoot break  
An MRI showed a small arachnoid cyst in the left middle cranial fossa, right occipital 
plagiocephaly and skull base dysplastic with a vertically orientated clivus. Postnatal CK and 
baseline metabolic screen were normal. Karyotyping, MYH3 genetic testing exons 5, 8-11, 
14-21 and 33, CHRNG, RAPSN and DOK7 genetic testing was normal. 
 
Case 3 
This male patient was born to non-consanguineous South American parents. Reduced fetal 
movements were noted towards the end of pregnancy. His birth weight was 2.83 kg (5 
percentile) and there were no neonatal problems. He required repair of bilateral inguinal 
herniae and bilateral tendon releases between his 1st and 2nd fingers of both hands and feet. 
He also had release of a tongue tie. At age 6 years he was short with poor muscle bulk. His 
height was on the 0.4 percentile, his weight below the 0.4 percentile and his head 
circumference between the 0.4 -2 percentile. There were no other concerns about his health or 
development. Facially he was hyperteloric with down-slanting palpebral fissures and low set 
ears. He had a low posterior hairline and neck webbing (see Figure 3). He had sloping 
shoulders and flexion contractures of his, elbows, wrists and fingers, with ulna deviation at 
the metacarpalphalangeal joints and soft tissue syndactyly of fingers 2-5 and flexion 
contractures affecting his hips, knees and ankles. He had a mild thoracic kyphoscoliosis and 
eleven pairs of downward sloping ribs  
On x-ray there was bilateral forefoot valgus deformities and hindfoot valgus. There was 
bilateral coxa vara. CHRNG genetic analysis was normal. 
 
